No CrossRef data available.
Article contents
Addressing Inadequacies in the Care of Patients with Schizophrenia and Bipolar Disorder
Published online by Cambridge University Press: 07 November 2014
Extract
Physicians treating patients with serious mental illness need to overcome a number of hurdles to ensure that appropriate health care is provided to these often underserved patients. The Community Mental Health Act of 1963 established community mental health centers (CMHCs) that provide patients with access to psychiatric care, with the unintended consequence of separating mental health care from physical care. CMHCs do not always have adequate resources to screen, monitor, and treat cardiovascular disease (CVD): they lack sufficient funding, have limited staff, and often do not have laboratory facilities for monitoring lipids and blood glucose.
- Type
- Clinical Information Supplement
- Information
- Copyright
- Copyright © Cambridge University Press 2008
References
1.
Nasrallah, HA, Newcomer, JW.
Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J Clin Psychopharmacol.
2004;24(5 Suppl 1):S7–14.CrossRefGoogle ScholarPubMed
2.
Nasrallah, H, McIntyre, R, Hennekens, C, Vogel-Scibilia, S. Translating clinical data into practice: a call-to-action to raise the standard of care in the treatment of schizophrenia and bipolar disorder [transcript]. Presented at: American Psychiatric Association Media Briefing; Toronto, Canada.Google Scholar
3.
Institute of Medicine (US). Committee on Crossing the Quality Chasm. Improving the Quality of Health Care for Mental and Substance-Use Conditions. Washington, DC: National Academy Press; 2006.Google Scholar
4.
Marder, SR, Essock, SM, Miller, AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry.
2004;161(8):1334–1349.Google Scholar
5.
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry.
2004;65(2):267–272.Google Scholar